Alcobra Ltd. to Release First Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on May 6
April 16, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, April 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Two CNS Focused Conferences in April
April 06, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, April 6, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra's MDX Meets Primary Endpoint in Phase II Safety and Tolerability Clinical Trial in Adolescents With ADHD
March 10, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, March 10, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at 27th Annual ROTH Conference
March 03, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, March 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Fourth Quarter and Fiscal Year 2014 Financial Results and Provides Corporate Update
February 12, 2015 07:30 ET
|
Alcobra Ltd.
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2014 Financial Results and Host Corporate Update Conference Call & Webcast on February 12
February 02, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at BIO CEO & Investor Conference
January 29, 2015 08:11 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
January 14, 2015 09:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 14, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) today reported that it has closed its previously announced public offering of ordinary shares. The Company sold 7,475,000...
Alcobra Ltd. Prices Public Offering of Ordinary Shares
January 09, 2015 09:06 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,500,000 ordinary shares at an offering...
Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares
January 08, 2015 16:19 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. The offering is subject...